Finally, gene microarray analysis of MS lesions has shown that transcript levels of FGF-12 and FGF-2 homolog are elevated 10.7- and 4.7-fold, respectively [62], and MS patients exhibit significantly elevated serum levels of FGF [63]. Here, FGF12 is linked to myeloid sarcoma.